What a urine N-methylhistamine result can show
Histamine itself disappears from blood quickly, so a urine metabolite can preserve part of the signal long enough to measure. Interpretation depends on the specimen, collection timing, age-specific laboratory interval, and whether a 24-hour collection was complete. Compare an acute result with the person's baseline and record whether the episode affected more than one body system. Those details can support or weaken a mast-cell question without turning every flush, headache, stomach symptom, or foggy day into MCAS.
Metabolite
Whether more histamine breakdown product reached this urine sample
N-methylhistamine lasts longer than histamine itself, so urine can retain evidence that a short-lived blood histamine measurement may miss.
Timing
Whether a planned event sample changed from baseline
A post-event spot sample compared with a later baseline can ask a different question from one 24-hour total collected during ordinary symptoms.
Support
What the result adds to a mast-cell or mastocytosis assessment
Read the result with tryptase, other urine mediators, event symptoms, allergy testing, medicines, and the specialist evaluation.
MCAS and mastocytosis need clinical criteria and other evidence. Food reactions, the histamine source, brain fog, and treatment also need their own assessment. US, UK, Canadian, and Australian pathways use this test differently.
Save this test
Save the exact urine test, collection time, symptoms, and result
Keep the value beside the specimen type, exact timing, collection quality, urine creatinine, event symptoms, medicines, other mediator results, and specialist interpretation. That makes a later baseline or repeat comparable.
My Fog stores the record. It does not validate the collection, diagnose MCAS or mastocytosis, interpret an emergency, or select treatment.
How do age, sex, pregnancy, kidney function, and collection ability affect the result?
Age changes the expected urine value. Sex, pregnancy, kidneys, urine creatinine, allergies, medicines, and collection quality can affect the result. There is no universal MCAS cutoff for men, women, pregnancy, or older adults.
Babies and children through age 5
Mayo's current example is 120 to 510 mcg/g creatinine, much higher than the adult interval. Collection may need instructions for children. Get child-specific emergency care for a sudden reaction without waiting for a 24-hour result.
Children and teenagers ages 6 through 16
Mayo's current example is 70 to 330 mcg/g creatinine. Levels reach adult values by about age 16, but the performing laboratory decides the printed interval. Growth, atopy, medicines, collection completeness, and the actual reaction still belong beside the number.
Adult women and men
Mayo uses the same N-methylhistamine range after age 16. A 2025 study of 4,033 tested patients found sex differences across urine mast-cell markers. It did not set separate universal MCAS cutoffs for women and men.
Pregnancy and breastfeeding
There is no universal cutoff for pregnancy or breastfeeding. Get emergency and pregnancy care for new trouble breathing, throat swelling, fainting, or widespread hives with vomiting or dizziness. A fast-changing severe reaction also needs immediate care.
Older adults, kidney change, and difficult collections
The lab reports the result against urine creatinine. Its 24-hour report includes collection duration, volume, and creatinine. Frailty, incontinence, kidney disease, dehydration, diuretics, and a missed sample can make collection or comparison harder. Ask whether a planned spot sample is safer and more useful than an unreliable full day.
How do you collect urine N-methylhistamine without losing the answer?
Ask which specimen answers the question. A 24-hour collection can describe excretion across a full day and may help with persistent elevation or a borderline spot result. Some services prefer a random urine sample collected soon after an episodic reaction and compared with a later baseline.
Get the laboratory's container, start time, storage, preservative, and return instructions before the collection begins. Mayo's current 24-hour protocol uses no preservative and prefers refrigerated transport, but another performing laboratory may use a different validated process.
Review every prescription, over-the-counter medicine, supplement, and recent emergency treatment with the ordering clinician. Monoamine oxidase inhibitors and aminoguanidine can raise N-methylhistamine. Do not stop either, or any antihistamine, mast-cell medicine, psychiatric medicine, or other prescription, unless the prescriber gives a safe plan.
Keep your usual food and fluid intake unless the lab says otherwise. Mayo says an average North American diet does not change the result much. A very high-histamine meal may raise it by about 30 percent, especially in a spot sample collected after the meal.
If this is a 24-hour test, choose a day when you can collect every urine passage. Empty the bladder into the toilet at the start and write down that time. Collect every passage after it, including the final urine at the same time the next day. Record any missed, spilled, or contaminated sample instead of hiding it.
If the aim is to catch a reaction, make a written plan before the next episode. Record symptom start, body systems involved, suspected exposure, treatment, urine collection time, and whether acute and baseline serum tryptase are also planned. Never provoke a reaction to create a positive test.
Choose 24-hour or post-event sampling
Use the sample type the clinician or lab requested and the performing service. A full-day collection and an acute spot sample with baseline comparison are not interchangeable records.
Save timing and collection quality
Keep start and end times, total volume, storage, preservative, missed samples, acute symptom timing, medicines, food context, and the urine creatinine result with the N-methylhistamine value.
Read the value against the right comparison
Use the printed age-specific interval. When acute and baseline samples were deliberately paired, compare those values too, but do not apply a research ratio as a universal personal cutoff.
Record why the test was ordered with the result
Read it with the event record, tryptase, other urine mediators, allergy evaluation, medicine exposures, kidney and creatinine context, and any mastocytosis assessment.
What does a urine N-methylhistamine result mean?
Start with sample type and collection quality, then use the printed age-specific interval. When an acute sample was deliberately paired with baseline, compare them. Finish with symptoms, tryptase, other mediators, allergy and mastocytosis questions, and the country-specific pathway.
Collection or timing is unclear
Collection, timing, storage, or comparison is unclear
Do not force an interpretation. Confirm whether this was a full 24-hour collection or a spot sample. Check collection and storage, medicines, recent meals, symptoms, and whether there is a baseline sample.
Inside the age-specific laboratory interval
Inside the performing laboratory's age-specific interval
The measured urine N-methylhistamine was not above that laboratory's interval in this specimen. This lowers concern only for a detectable rise under those collection conditions. It does not rule out anaphylaxis, MCAS, mastocytosis, allergy, or another cause of the symptoms.
Above the interval or higher than baseline
Above the interval or meaningfully higher than a comparable baseline
The result supports increased histamine-metabolite excretion, but it does not identify the source or diagnosis. Review the degree of rise, age, diet, medicines, allergies, symptoms, tryptase, other urine mediators, collection quality, and whether the question is mastocytosis or another allergic process.
A severe systemic reaction is happening now
A severe systemic reaction is happening now, whatever the urine result
Trouble breathing, throat or tongue swelling, fainting, collapse, severe wheeze, rapidly spreading hives with vomiting or dizziness, or symptoms affecting several systems can be anaphylaxis. Follow the emergency plan and use emergency services. Do not wait for urine collection or a result.
An adult upper limit of 200 is not an MCAS diagnosis
Children have higher intervals, mild rises can occur without MCAS, and normal values can occur in people with real mast-cell disorders or anaphylaxis. The event details, acute-versus-baseline change, other mediator evidence, collection quality, and competing causes decide what the number adds.
See research details
These checks keep the collection method, age ranges, country disagreement, paired sampling, current 2025 evidence, sex context, and mastocytosis limits separate.
Use the interval printed by the performing laboratory. The adult upper limit isn't a universal MCAS cutoff. Read children's values against their own age ranges.
Decide before the event which sample the service wants. Save sample type, symptom timing, collection duration, total volume, and the baseline plan so you can compare the result correctly.
If you missed or spilled any urine, tell the laboratory. Do not quietly extend the collection or present an incomplete day as complete.
Do not diagnose MCAS from one urine value or from persistent nonspecific symptoms. Record which body systems were affected during the episode. Keep that record with acute and baseline samples, other mediator results, the allergy workup, and the response plan.
The 2025 review calls paired urine mediators emerging biomarkers. Treat an acute-to-baseline ratio as supportive research-informed evidence, not a universal diagnostic threshold or a reason to ignore tryptase and the clinical criteria.
A high baseline alone isn't enough for a diagnosis. The planned event sample and later comparison matter more than repeatedly testing unrelated foggy days.
Use the local immunology service's specimen and transport instructions. Do not copy a US kit schedule onto a UK referral sample.
If care is in Australia or New Zealand, ask the clinical immunologist whether the urine result will change the workup. The test is available but isn't recommended for every suspected case.
Do not apply the study's ratios to a routine Mayo mcg/g creatinine result or use them as an MCAS threshold. Method, units, population, and clinical purpose are different.
Use the value to decide what clinical and specialist assessment makes sense. Do not convert it into mastocytosis, idiopathic MCAS, or a personal probability of either condition.
The study did not establish a universal male-versus-female N-methylhistamine cutoff for MCAS. Use the performing laboratory's interval and keep sex, age, atopy, smoking, body size, and the other mediators in context.
Make the next reaction and sample easier to understand
You can improve the quality of this investigation without trying to force the number up or down. The useful work is to capture a real event safely, preserve the specimen, and keep the alternatives visible.
Make a one-page reaction record
For each sudden episode, record the start time and changes in skin, swelling, breathing, heart rate, or fainting. Add vomiting, diarrhea, cramps, possible food or sting, medicine, heat, exercise, alcohol, infection, and treatment. Mark which symptoms happened together.
Prepare the sample plan before the next event
Keep the order, container, collection instructions, laboratory phone number, storage plan, and acute-versus-baseline timing in one place. Ask what should happen if the episode occurs at night, at work, while travelling, or during emergency treatment.
Avoid only triggers you have clearly identified
Follow an existing allergy or anaphylaxis plan and avoid a trigger you've already identified. Do not provoke symptoms, stop needed medicine, fast, dehydrate yourself, or remove dozens of foods to make the test more convincing. A short food record is safer and more informative than an indefinite low-histamine diet from one urine number.
Ask what result would change the plan
Before repeating the test, ask what decision it will change. The question may need an event and baseline sample, blood tryptase, other urine markers, allergy testing, mastocytosis testing, or another explanation. It isn't a test to repeat routinely.
Use the prescribed anaphylaxis plan and call 911 for trouble breathing, throat or tongue swelling, fainting, collapse, severe wheezing, blue or very pale skin, or confusion. A fast-worsening reaction in more than one body system is also an emergency. Get help first. Urine can wait, and this page can't guide treatment.
What should you keep with a urine N-methylhistamine result?
Keep these together
- Twenty-four-hour or spot sample, and acute or baseline purpose
- Value, unit, age-specific laboratory interval, assay, and performing laboratory
- Urine creatinine, collection duration, total volume, start and end times
- Container, preservative, storage temperature, return time, and any missed or spilled urine
- Symptom start, body systems involved, suspected exposure, severity, and emergency treatment
- MAO inhibitors, aminoguanidine, antihistamines, mast-cell medicines, supplements, and recent medication changes
- Food and alcohol context, atopy, infection, heat, exercise, menstruation, pregnancy, and kidney context when relevant
- Acute and baseline serum tryptase, other urine mediators, allergy tests, KIT or mastocytosis findings when ordered
- Clinician interpretation, criteria met and not met, safety plan, action, and reason for any repeat
Question for the visit
“Ask whether this urine mediator sample was collected at the right time and how it compares with baseline. Clarify which mast-cell diagnosis it can support and what result would change care.”
Sources for Urine N-Methylhistamine Test: Collection and Results
Current 2026 procedure, age-specific intervals, LC-MS/MS method, medicines, diet, storage, and interpretation limits
Current spot-sample pathway, chronic versus episodic use, creatinine correction, variability, and age ranges
US academic laboratory confirmation of age-specific Mayo send-out intervals
Human collection sequence, refrigeration, final sample, labeling, and medicine disclosure
Current US public pathway, systemic episodes, acute and baseline tryptase, urine mediators, and specialist planning
Emergency symptoms and treatment boundary
Current laboratory strategy, consensus role of tryptase, urine mediator options, KIT testing, and mastocytosis context
UK post-reaction spot, later baseline, 24-hour MCAS collection, freezing, and referral pathway
UK specialist referral-laboratory availability and accreditation context
Australian MCAS criteria, tryptase preference, non-recommendation of urine histamine metabolites, and cutoff limits
AAAAI workgroup MCAS criteria, urine N-methylhistamine limitations, cell-source ambiguity, and further-research need
Urine mediator review for systemic mastocytosis and contemporaneous mast-cell activation
Selected acute-versus-baseline mediator ratios accompanying a qualifying tryptase rise and generalizability limits
Urine mediator review, noninvasive collection, emerging evidence, and need to complement tryptase
Current biomarker review, acute and baseline urine strategy, collection window, and unsettled thresholds
Current Canadian consensus-based clinical pathway, 3-to-6-hour urine timing, and normal or high baseline limits
4,033-person sex-differences cohort, testing imbalance, wider mediator context, and lack of a new universal NMH cutoff
Validated alternative LC-MS/MS assay, systemic mastocytosis and hereditary alpha tryptasemia groups, and ratio-purpose limits
703-adult specialist referral cohort, 31 strict idiopathic MCAS diagnoses, and overdiagnosis limit
Thirty-seven selected high-NMH mastocytosis referrals and lack of one-to-one bone-marrow correlation
See each claim's sources
range
Current Mayo LC-MS/MS examples are 120 to 510 mcg/g creatinine through age 5, 70 to 330 from ages 6 through 16, and 30 to 200 after age 16.procedure
A 24-hour result requires a complete timed specimen, recorded duration and volume, and laboratory-specific storage; episodic questions may instead use a timed random sample and baseline comparison.limitation
MAO inhibitors and aminoguanidine can raise urine N-methylhistamine, and a very histamine-rich diet can produce a mild rise of about 30 percent, especially in a post-meal random sample.limitation
One urine N-methylhistamine result does not diagnose or exclude MCAS; recurrent systemic symptoms, event-related objective mediator evidence, treatment response, and competing causes remain part of the assessment.interpretation
A selected retrospective series linked acute-to-baseline urine mediator rises near 1.3 with a qualifying serum tryptase rise, but current reviews describe these ratios as emerging rather than universal diagnostic cutoffs.limitation
US and UK services use urine N-methylhistamine as supporting evidence in selected pathways, while ASCIA's 2025 position paper does not recommend it for MCAS investigation because diagnostic cutoffs and utility remain insufficiently established.limitation
Some people with mastocytosis or anaphylaxis remain within the interval, while healthy people can sit just above it, so normal and mildly high values both require collection and clinical context.interpretation
Alheraky 2025 validated a separate LC-MS/MS assay in selected systemic mastocytosis and hereditary alpha tryptasemia groups; its serum-tryptase-to-metabolite ratios are not routine MCAS thresholds for other assays and units.context
A 2025 review of 4,033 tested patients found sex differences in the wider urinary-mediator population but did not establish separate universal male and female N-methylhistamine MCAS cutoffs.limitation
Elevated urine N-methylhistamine does not identify mastocytosis or bone-marrow involvement by itself.limitation
In a 703-adult specialist referral cohort, 31 people met strict idiopathic MCAS criteria, showing why suspected symptoms or one laboratory value should not be treated as confirmation.safety
Suspected anaphylaxis requires the person's emergency plan and immediate treatment; urine collection must not delay emergency care.